2017
DOI: 10.1136/bcr-2017-222030
|View full text |Cite
|
Sign up to set email alerts
|

5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer

Abstract: 5-Fluorouracil (5-FU), a commonly used antimetabolite and antineoplastic agent, has been approved for treatment of various cancers. Neurotoxicities are considered extremely rare side effects of 5-FU. We present a case of 5-FU-induced encephalopathy with diffusion-restricted reversible lesion of the splenium of the corpus callosum in a patient with colorectal cancer. The patient presented with confusion, dysarthria and agitation after 5-FU infusion. The prognosis of this toxic effects of 5-FU is usually good if… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 20 publications
0
13
0
Order By: Relevance
“…Transient, reversible lesions in the splenium have been described in a wide range of disorders, including viral, bacterial and parasitic infections, treatment of infection with metronidazole, anti-epileptic drug (AED) toxicity or withdrawal, treatment with 5 fluorouracyl, hypoglycemia, hyponatremia and high altitude cerebral edema [31,32,[34][35][36]. Similar lesions have been described on MRI in patients with Wernicke syndrome, with persisting cognitive impairment following thiamine replacement.…”
Section: A1reversible Splenial Lesionsmentioning
confidence: 78%
“…Transient, reversible lesions in the splenium have been described in a wide range of disorders, including viral, bacterial and parasitic infections, treatment of infection with metronidazole, anti-epileptic drug (AED) toxicity or withdrawal, treatment with 5 fluorouracyl, hypoglycemia, hyponatremia and high altitude cerebral edema [31,32,[34][35][36]. Similar lesions have been described on MRI in patients with Wernicke syndrome, with persisting cognitive impairment following thiamine replacement.…”
Section: A1reversible Splenial Lesionsmentioning
confidence: 78%
“…Literature review disclosed 26 similar cases (Figure S1, panel B) [9–32], whose clinical−paraclinical features are reported in Table S1. Fifteen patients were female and eleven were male, with a median age of 50.5 (range 23–80) years.…”
Section: Resultsmentioning
confidence: 99%
“…Control MRI, available for 19/26 patients, showed the resolution of diffusion abnormalities but the common persistence of residual T2/FLAIR hypersignal (median time to control MRI 4 weeks, range 1–40 weeks). A single patient reintroduced 5‐FU at a lower dose with no recurrence of neurotoxicity, though it was discontinued early because of intervening tumor progression [26].…”
Section: Resultsmentioning
confidence: 99%
“…CNS toxicity is uncommon and is limited to very few case reports. [ 1 2 3 ] CNS toxicity occurs in the form of sudden onset of slurred speech, confusion, cognitive disturbances, and paranoia. These symptoms usually develop within 7 days from the beginning of the chemotherapy cycle as seen in our patient (on Day 3) and resolve on discontinuation of the drug.…”
Section: Discussionmentioning
confidence: 99%